UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 OR 15(d) of
                       the Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported) March 2, 2007


                              INVACARE CORPORATION
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


           Ohio                    1-15103                      95-2680965
--------------------------------------------------------------------------------
(State or other jurisdiction     (Commission                (IRS Employer
     of incorporation)            File Number)               Identification No.)


One Invacare Way, P.O. Box 4028, Elyria, Ohio                           44036
---------------------------------------------                         ----------
(Address of principal executive offices)                              (Zip Code)

     Registrant's telephone number, including area code: (440) 329-6000
                                                         --------------


--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))




Item 5.02.Departure  of Directors or Certain  Officers;  Election of  Directors;
          Appointment of Certain Officers;  Compensatory Arrangements of Certain
          Officers.

     Effective  March 2, 2007,  the Board of Directors  of Invacare  Corporation
(the  "Company")  elected  General  James L. Jones,  United  States Marine Corps
(ret.),  as a member  of the Board of  Directors  on the  recommendation  of the
Nominating Committee of the Board of Directors. General Jones was elected to the
class of directors who will stand for  re-election  to a three-year  term at the
Company's 2007 Annual Meeting of Shareholders.  General Jones has been appointed
to serve as a member of the Investment and Nominating Committees of the Board of
Directors.

     General Jones, age 63, recently retired as Supreme Allied Commander of NATO
(North Atlantic Treaty  Organization)and Commander of the United States European
Command.  Prior to becoming  Supreme  Allied  Commander of NATO,  General  Jones
served as  Commandant  of the Marine  Corps.  General  Jones has a  Bachelor  of
Science degree and an Honorary  Doctorate  from  Georgetown  University.  He was
commissioned  into the  Marine  Corps in 1967 and served in Vietnam as a platoon
and company  commander.  He graduated  from the National War College in 1985 and
later served as Military Assistant to the U.S. Secretary of Defense.

     There is no  arrangement  or  understanding  between  General Jones and any
other person  pursuant to which  General  Jones was elected as a director of the
Company.  There are no  transactions in which General Jones has an interest that
are required to be disclosed under Item 404(a) of Regulation S-K.

     On  March 2,  2007,  the  Company  issued a press  release  announcing  the
election of General Jones, which is attached hereto as Exhibit 99.1.


Item 9.01. Financial Statements and Exhibits.

         (c) Exhibits.

Exhibit number       Description
--------------       -----------
99.1                 Press Release of Invacare Corporation, dated March 2, 2007.







                                   SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                                    Invacare Corporation
                                                    (Registrant)

Date:  March 2, 2007                                /s/ Gregory C. Thompson
                                                    ----------------------------
                                                    Gregory C. Thompson
                                                    Senior Vice President and
                                                    Chief Financial Officer










                                  Exhibit Index


Exhibit number       Description
--------------       -----------
99.1                 Press Release of Invacare Corporation, dated March 2, 2007.